| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |